Article Sidebar
Published:
Feb 18, 2023DOI:
10.4314/tjpr.v22i1.8Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
MicroRNA 744 induces apoptosis and autophagy in human gastric cancer by targeting heparanase-1
Abstract
Purpose: To study the possible anti-cancer effects of miR-744 on human gastric cancer cells, and the underlying mechanism.
Methods: The mRNA expression of miR-744 was determined using qRT-PCR, while CCK-8, Annexin V/PI and acridine orange assays were used to determine cell viability, apoptosis and autophagy, respectively. The expressions of target proteins were determined using qRT-PCR and Immunoblotting.
Results: Significant suppressions of miR-744 were observed in gastric cancer tissues and cell lines. Overexpression of miR-744 inhibited the proliferation while silencing of miR-744 promoted the proliferation of gastric cancer cells. Furthermore, the tumor-suppressive effect of miR-744 in gastric cancer was due to induction of apoptosis and autophagy. Heparanase-1 (HPSE-1) was identified as the target of miR-744. Silencing of HSPE-1 significantly inhibited cell proliferation, whereas its overexpression significantly restored the growth-inhibitory effects of miR-744 overexpression on gastric cancer (p < 0.05).
Conclusion: These results indicate that miR-744 exerts a tumor-suppressive effect on the growth and proliferation of gastric cancer cells in vitro by targeting HPSE-1. There is need to further determine the anti-cancer effect of miR-744 expression in animal models.
